Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $1,264,742 (100.0% shares, 0.0% debt)

Holdings (32)

BMRN BIOMARIN PHARMACEUTICAL INC 13.2%
Value ($000) $167,528 Shares 1,976,265 Est. Cost $83.16 Unrealized +7.1%
UTHR UNITED THERAPEUTICS CORP 10.5%
Value ($000) $132,649 Shares 633,534 Est. Cost $89.23 Unrealized +150.5%
INSM INSMED INC 9.9%
Value ($000) $125,802 Shares 5,840,398 Est. Cost $17.79 Unrealized +34.8%
ABIOMED INC 9.5%
Value ($000) $120,559 Shares 490,754 Est. Cost $81.43 Unrealized
REVANCE THERAPEUTICS INC 9.4%
Value ($000) $118,936 Shares 4,405,039 Est. Cost $21.99 Unrealized
FOLD AMICUS THERAPEUTICS INC 8.1%
Value ($000) $102,811 Shares 9,847,774 Est. Cost $9.52 Unrealized +17.1%
PRTA PROTHENA CORP PLC 7.9%
Value ($000) $100,026 Shares 1,649,777 Est. Cost $21.46 Unrealized +47.3%
BIIB BIOGEN INC 7.6%
Value ($000) $96,382 Shares 360,981 Est. Cost $264.06 Unrealized -19.6%
STAA STAAR SURGICAL CO 6.1%
Value ($000) $77,385 Shares 1,096,882 Est. Cost $14.28 Unrealized +499.5%
SAGE THERAPEUTICS INC 2.6%
Value ($000) $33,341 Shares 851,409 Est. Cost $46.62 Unrealized
KARYOPHARM THERAPEUTICS INC 2.4%
Value ($000) $30,694 Shares 5,621,533 Est. Cost $16.36 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.2%
Value ($000) $27,455 Shares 1,678,196 Est. Cost $33.89 Unrealized -52.2%
VNDA VANDA PHARMACEUTICALS INC 1.7%
Value ($000) $21,402 Shares 2,166,156 Est. Cost $11.21 Unrealized -5.8%
GOSS GOSSAMER BIO INC 1.7%
Value ($000) $20,973 Shares 1,750,651 Est. Cost $11.85 Unrealized +4.8%
SNDX SYNDAX PHARMACEUTICALS INC 1.2%
Value ($000) $14,721 Shares 612,600 Est. Cost $16.84 Unrealized +33.3%
ALKS ALKERMES PLC 1.1%
Value ($000) $13,474 Shares 603,400 Est. Cost $22.36 Unrealized +16.3%
ANAB ANAPTYSBIO INC 0.9%
Value ($000) $10,995 Shares 431,024 Est. Cost $19.06 Unrealized +23.0%
ALGN ALIGN TECHNOLOGY INC 0.7%
Value ($000) $9,176 Shares 44,305 Est. Cost $114.31 Unrealized +125.2%
EHTH EHEALTH INC 0.6%
Value ($000) $7,734 Shares 1,977,993 Est. Cost $50.83 Unrealized -86.3%
GRITSTONE ONCOLOGY INC 0.5%
Value ($000) $5,989 Shares 2,330,504 Est. Cost $9.42 Unrealized
KEZAR LIFE SCIENCES INC 0.4%
Value ($000) $5,650 Shares 656,200 Est. Cost $5.16 Unrealized
CYTK CYTOKINETICS INC 0.4%
Value ($000) $5,413 Shares 111,717 Est. Cost $6.71 Unrealized +616.9%
CLOVIS ONCOLOGY INC 0.4%
Value ($000) $5,324 Shares 4,473,967 Est. Cost $42.71 Unrealized
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value ($000) $4,092 Shares 166,069 Est. Cost $23.56 Unrealized +9.7%
PROVENTION BIO INC 0.1%
Value ($000) $1,759 Shares 390,800 Est. Cost $4.50 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value ($000) $1,359 Shares 64,700 Est. Cost $15.56 Unrealized +54.8%
ALIMERA SCIENCES INC 0.1%
Value ($000) $1,021 Shares 200,919 Est. Cost $6.30 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value ($000) $859 Shares 160,800 Est. Cost $7.10 Unrealized -15.5%
MAGENTA THERAPEUTICS INC 0.0%
Value ($000) $610 Shares 432,300 Est. Cost $7.38 Unrealized
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value ($000) $211 Shares 27,100 Est. Cost $39.74 Unrealized -79.0%
MARINUS PHARMACEUTICALS INC 0.0%
Value ($000) $208 Shares 31,330 Est. Cost $15.48 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $204 Shares 24,500 Est. Cost $27.01 Unrealized -69.4%